The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCizzle Biotech Share News (CIZ)

Share Price Information for Cizzle Biotech (CIZ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.60
Ask: 1.80
Change: 0.00 (0.00%)
Spread: 0.20 (12.50%)
Open: 1.70
High: 1.70
Low: 1.70
Prev. Close: 1.70
CIZ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Fiinu teams with TransUnion; GRC wins pact

Fri, 23rd Dec 2022 18:15

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Fiinu PLC - Surrey, England-based fintech company - Says information and insights company TransUnion is supporting Fiinu Bank's overdraft solution platform through TransUnion's open banking offering and credit reference data. "This information will provide an in-depth understanding of a consumer's financial situation and help Fiinu, which is a registered bank, to deliver robust open banking-driven eligibility checks of consumers applying for an overdraft," Fiinu adds.

----------

GRC International Group PLC - Ely, England-based provider of products and services for IT governance, risk management and compliance - Says IT governance wins G-Cloud 13 framework contract. Will provide more than 100 of its products and services through UK government's digital marketplace. "This eliminates the need for its customers to go through a full tender process," GRC adds. "Launched in 2012, G-Cloud 13 is an online catalogue and the newest iteration of the G-Cloud framework, which is used by the UK public sector to identify and acquire a diverse range of cloud-based computing services."

----------

Eco Atlantic Oil & Gas Ltd - Toronto-based oil and gas exploration company - Receives approval from South Africa's Department of Mineral Resources & Energy and Petroleum Agency of South Africa for acquisition of additional interest in Block 3B/4B. Now holds interest of just over 26%.

----------

Corre Energy BV - Groningen, Netherlands-based renewable energy storage solutions and green hydrogen producer - Signs binding commercial terms for a 15-year offtake agreement with renewable power supplier Eneco. Deal concerns entire storage capacity of the Zuidwending compressed air energy storage in Netherlands. "Under the terms of the arrangement, Corre Energy will construct, operate and maintain the facility and Eneco will optimise the entire output of the storage site on behalf of Corre Energy. Eneco will provide market access services, enabling Corre Energy to benefit from revenue linked to the high flexibility value of the asset, while also guaranteeing a base level of income," Corre adds.

----------

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Agrees put option to sell 5% interest in AZD 1656 asset, which treats inflammatory pulmonary and cardiovascular disease. Also sells royalty sharing agreement with St George Street Capital. Both sold to Conduit Pharmaceuticals Ltd for GBP3.3 million, to be satisfied in shares. In addition, Cizzle raises GBP115,586 through subscription of 7.4 million new shares at 1.6 pence each.

----------

Kropz PLC - African phosphate developer - Says in process of engaging with possible successor to Mark Summers as chief executive officer. "The formal appointment and announcement are expected to be finalised in early January 2023. In the meantime, Mark Summers has agreed to remain as CEO until the appointment is formalised," Kropz adds. Summers, and outgoing operating chief Michelle Lawrence, are staying with Kropz under short-term consulting agreements. Kropz adds: "Progress is being made with regards to the first bulk concentrate sale from Kropz Elandsfontein. The sale of approximately 30,000 tonnes of concentrate is expected to ship in early 2023. The product, which has been generated throughout the commissioning and ramp up period, will be sold at a discount to current market prices."

----------

Star Phoenix Group Ltd - oil and gas company focused on Trinidad and Indonesia - Will be unable to appoints its new auditor or publish its results for the year ended June 30 by the end of 2022, as resolutions at its general meeting on Monday are rejected by shareholders. Shareholders vote for the removal of the auditor and against the appointment of a new auditor. As a result, the oilfield services company's share will be suspended from trading on AIM from the morning of January 3.

----------

abrdn China Investment Co Ltd - Invests predominantly in Chinese equities - Gets regulatory approval for qualified foreign investor licence. Allows it "access to a broader investible universe within Chinese equities".

----------

Triple Point Social Housing REIT PLC - London-based real estate investment trust - Notes Regulator of Social Housing takes enforcement action against My Space Housing Solutions, or My Space. My Space ratings downgraded to V4 for viability and G4 for governance, from V3 and G3, respectively. Triple Point Social Housing has 34 properties leased to My Space, representing 7.5% of contracted rent roll. Triple Point adds: "The group's investment manager, Triple Point Investment Management LLP, continues to engage actively with My Space regarding improvements to its operations, with the aim of increasing rental payments and agreeing a payment schedule in respect of rent arrears. The manager also notes that My Space has sought to address a number of the concerns noted in today's regulatory judgement. However, as part of the ongoing engagement with My Space, the group will consider whether it is appropriate to put in place alternative arrangements for some or all of its properties."

----------

PureTech Health PLC - Boston, US-based biotherapeutics company - Says trial results find LYT-300 achieves blood levels of allopregnanolone "at or above those associated with therapeutic benefit". Chief Medical Officer Julie Krop adds: "Today's results make us very excited about the potential of LYT-300 to unlock the full therapeutic benefit of allopregnanolone, which to date has been limited to a small subset of patients."

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.

More News
23 Nov 2022 16:58

IN BRIEF: Cizzle Biotechnology signs lung-cancer study in China

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Signs further Memorandum of Understanding with International Co-Innovation Centre for Advanced Medical Technology for a clinical pilot study with the Cancer Hospital Chinese Academy of Medical Sciences, National Cancer Center of China. The clinical pilot study will evaluate optimised assays using a monoclonal antibody that Cizzle Biotechnology has developed that specifically detects CIZ1B, which is highly associated with stage 1 lung cancer.

Read more
9 Nov 2022 20:41

UPDATE: Cizzle, Vela Technologies notes planned Conduit Pharma merger

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - and Vela Technologies PLC - Bradford, England-based investment firm focused on early-stage and pre-IPO disruptive technology investments - Notes announcement by Conduit Pharmaceuticals Ltd that it intends to become a publicly traded company on the Nasdaq in the US through a merger with special purpose acquisition firm Murphy Cannon Acquisition Corp. The deal is expected to generate USD149.7 million worth of proceeds for Conduit.

Read more
28 Sep 2022 14:43

Cizzle Biotechnology reports narrowed loss as passes "key milestones"

(Alliance News) - Cizzle Biotechnology Holdings PLC on Wednesday said it had passed "key milestones" as it moved towards generating revenue for its products.

Read more
18 Aug 2022 11:37

Vela Tech, Cizzle Biotech shares jump on investee's trial results

(Alliance News) - Vela Technologies PLC and Cizzle Biotechnology Holdings PLC on Thursday hailed the latest clinical trial results from investee St George Street Capital Ltd.

Read more
5 Jul 2022 12:15

Cizzle Biotechnology expands use of lung cancer test

(Alliance News) - Cizzle Biotechnology Holdings PLC on Tuesday said that it is using its early-stage lung cancer test technology to detect more cancer types, notably breast cancer.

Read more
20 Jun 2022 15:40

UK shareholder meetings calendar - next 7 days

Tuesday 21 June 
1Spatial PLCAGM
Altus Strategies PLCAGM
Coca-Cola HBC AGAGM
FireAngel Safety Technology Group PLCAGM
HC Slingsby PLCAGM
HSS Hire Group PLCAGM
Mission Group PLCAGM
Novacyt SAAGM
Pendragon PLCAGM
RTW Venture Fund LtdAGM
Velocys PLCAGM
Wednesday 22 June 
ASA International Group PLCAGM
Atalaya Mining PLCAGM
Bonhill Group PLCAGM
Chapel Down Group PLCAGM
Churchill China PLCAGM
Downing Renewables & Infrastructure Trust PLCGM re share issue
Ecofin US Renewables Infrastructure Trust PLCAGM
EJF Investments LtdAGM
Frenkel Topping Group PLCAGM
Good Energy Group PLCAGM
Honeycomb Investment Trust PLCAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Intelligent Ultrasound Group PLCAGM
Iofina PLCAGM
John Wood Group PLCAGM
Kingfisher PLCAGM
LXi REIT PLCGM
Menhaden PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Pennant International Group PLCAGM
Plant Health Care PLCAGM
Skillcast Group PLCAGM
Team PLCAGM
Tribal Group PLCGM re final dividend
Trident Royalties PLCAGM
Vertu Motors PLCAGM
Wentworth Resources PLCAGM
Thursday 23 June 
Avacta Group PLCAGM
Anglo Asian Mining PLCAGM
Card Factory PLCAGM
Cordiant Digital Infrastructure LtdAGM
Downing Renewables & Infrastructure Trust PLCGM re initial placing & open offer
Eight Capital Partners PLCGM re aligning 2022 bonds with 2026 bonds
GENinCode PLCAGM
Ideagen PLCGM re takeover by Hg Pooled Management Ltd
Longboat Energy PLCAGM
Oxford Nanopore Technologies PLCAGM
Puma VCT 13 PLCGM re cancellation of listing & liquidation
RBG Holdings PLCAGM
Tandem Group PLCAGM
Union Jack Oil PLCAGM
Zinnwald Lithium PLCAGM
Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
16 Jun 2022 16:55

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 May 2022 12:32

IN BRIEF: Cizzle Biotechnology widens annual loss on acquisition costs

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Posts higher annual loss in 2021. Pretax loss widens to GBP4.0 million from GBP14,000 in 2020. In May 2021, Cizzle was bought by Bould Opportunities PLC. Acquisition-related costs stand at GBP3.1 million in 2021 versus none in 2020.

Read more
6 May 2022 11:18

AIM WINNERS & LOSERS: SDI upbeat; Westminster rises on contract win

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
6 May 2022 10:11

Cizzle Biotechnology shares jump on US lung cancer collaboration

(Alliance News) - Cizzle Biotechnology Holdings PLC on Friday announced a new collaboration into lung cancer testing with a US partner.

Read more
11 Apr 2022 21:14

TRADING UPDATES: WANdisco bookings up; STM legal appeal denied

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
8 Mar 2022 06:45

IN BRIEF: Cizzle Biotech notes promising data from Arcadia study

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Reports that Arcadia clinical study shows potential value of AZD1656 treatment for Covid-19 patients. The new data analysis comes from St George Street Capital Ltd, which runs the trial with Excalibur Medicines Ltd for the treatment, in which Cizzle holds a "significant" royalty-bearing economic interest.

Read more
14 Feb 2022 15:26

Cizzle Biotechnology acquires further 5% interest in Covid treatment

(Alliance News) - Cizzle Biotechnology Holdings PLC shares jumped on Monday after it announced that it acquired an additional 5% interest in the commercialisation of the Covid-19 treatment AZD 1656.

Read more
3 Feb 2022 22:31

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.